Screening for Liver Fibrosis by Using Non-invasive Methods in Patients With Diabetes. A Prospective Study
NCT01306110 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 277
Last updated 2016-01-08
Summary
The aim of this study is to evaluate liver fibrosis using FibroScan and biochemical markers in patients with diabetes.
Conditions
Sponsors & Collaborators
-
Association HGE CHU Bordeaux Sud
lead OTHER
Principal Investigators
-
Victor De Ledinghen, MD PhD · University Hospital, Bordeaux
-
Juliette Foucher, MD · University Hospital, Bordeaux
-
Julien Vergniol, MD · University Hospital, Bordeaux
-
Vincent Rigalleau, MD PhD · University Hospital, Bordeaux
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
- Primary Completion
- 2010-12-31
- Completion
- 2010-12-31
Countries
- France
Study Locations
More Related Trials
-
Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods.
NCT04553796 ·Status: UNKNOWN
-
FIBROSCAN Validation and Interest of Fibrotest - FIBROSCAN Association for Fibrosis Diagnosis in Alcoholic Liver Disease
NCT00708617 ·Status: COMPLETED
-
Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis
NCT02575625 ·Status: UNKNOWN ·Phase: NA
-
Prevalence of NAFLD in T1DM Patients
NCT06445361 ·Status: RECRUITING ·Phase: NA
-
Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database
NCT02897908 ·Status: RECRUITING
-
Study Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus Patients
NCT04493814 ·Status: UNKNOWN
-
Liver Fibrosis and Steatosis in dm Non Invasive Evaluation
NCT05605717 ·Status: UNKNOWN
-
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
NCT04232293 ·Status: COMPLETED ·Phase: NA
-
Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.
NCT04435054 ·Status: COMPLETED ·Phase: NA
-
Validation of the New Vibration-guided FibroScan Examination
NCT05567328 ·Status: COMPLETED ·Phase: NA
-
Prospective Cohort Study in Patients With NAFLD
NCT00575133 ·Status: RECRUITING
-
Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD
NCT04774302 ·Status: COMPLETED
-
Prognosis Value of Transient Elastography and Non-invasive Markers of Fibrosis in Patients With Chronic Liver Disease
NCT01241227 ·Status: COMPLETED
-
Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
NCT02060565 ·Status: RECRUITING
-
Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis
NCT06160271 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease
NCT02779946 ·Status: COMPLETED
-
Type 2 DIAbeTes With NAFLD: innOvative Biomarkers of Disease progressioN and clInical outComes
NCT06567990 ·Status: RECRUITING ·Phase: NA
-
Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease
NCT01360879 ·Status: UNKNOWN
-
FibroTouch Non-invasive Evaluation of Liver Fibrosis and Cirrhosis
NCT02476695 ·Status: COMPLETED
-
Diagnosis of Fatty Pancreas by FibroScan
NCT07255989 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Assessment of Liver Fibrosis in a French Cohort of Pediatric Patients With Type III Glycogen Storage Disease: Current State and Perspectives
NCT07303140 ·Status: RECRUITING
-
Validation in a Non-targeted Population of Single Ultrasound Doppler Signs of Liver Fibrosis
NCT03027921 ·Status: UNKNOWN ·Phase: NA
-
Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients
NCT00926224 ·Status: COMPLETED ·Phase: NA
-
Spleen Stiffness Measurement With FibroScan
NCT02180113 ·Status: COMPLETED ·Phase: NA
-
Identification and Validation of Noninvasive Biomarkers of the Diagnosis and Severity of NASH in Type 2 Diabetics
NCT03634098 ·Status: COMPLETED ·Phase: NA